Article
Circulating immune cells and risk of osteosarcoma: a Mendelian randomization analysis.
Frontiers in immunology - 1 Jan 2024
Li Lan, Sun Yeqi, Luo Jia, Liu Mengjiao
Abstract excerpt
Objectives: Osteosarcoma (OS) is the primary bone tumor originating from transformed mesenchymal cells. It is unclear whether associations between specific circulating immune cells and OS are causal or due to bias. To clarify whether predicted genetically altered circulating immune cells are associated with OS development, we performed a two-sample Mendelian randomization (MR) analysis. Methods: The genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
